Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$21.39 - $35.9 $7.81 Million - $13.1 Million
-365,016 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$24.84 - $36.12 $6.06 Million - $8.81 Million
243,940 Added 201.48%
365,016 $12.5 Million
Q4 2021

Feb 14, 2022

SELL
$33.38 - $59.25 $2.68 Million - $4.77 Million
-80,437 Reduced 39.92%
121,076 $4.22 Million
Q3 2021

Nov 15, 2021

SELL
$53.75 - $76.55 $3.64 Million - $5.18 Million
-67,681 Reduced 25.14%
201,513 $11 Million
Q2 2021

Aug 10, 2021

BUY
$59.02 - $78.8 $444,538 - $593,521
7,532 Added 2.88%
269,194 $20.4 Million
Q1 2021

May 14, 2021

BUY
$64.61 - $113.09 $830,626 - $1.45 Million
12,856 Added 5.17%
261,662 $20 Million
Q4 2020

Feb 11, 2021

BUY
$48.06 - $84.4 $623,962 - $1.1 Million
12,983 Added 5.51%
248,806 $19.7 Million
Q3 2020

Nov 13, 2020

BUY
$46.87 - $93.33 $11.1 Million - $22 Million
235,823 New
235,823 $11.2 Million

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.19B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.